Article Listing - Adding Tarceva to Nexavar no better than Nexavar alone for liver cancer

REDUCING ASTHMA COSTS IN THE USA

6 April 1992

A study looking at the economic aspect of asthma in the USA has found that there are a number of...

ICN-GALENIKA "HEALTHY SHARES"

6 April 1992

Yugoslavia's Tanjug news agency reports that Milan Panic, head of ICN-Galenika and founder of US-based ICN Pharmaceuticals, is saying the...

GALLUP SURVEYS UK GPs ON HEPATITIS A

6 April 1992

With the recent introduction of its hepatitis A vaccine Havrix to the UK market, SmithKline Beecham has sponsored a Gallup...

NEW US IMPLANT REGULATIONS

6 April 1992

The US Food and Drug Adminis-ration plans to require manufacturers of high-risk medical devices to track new patients closely, so...

BAYER DIAGNOSTICS' NEW INSTRUMENT

6 April 1992

Bayer Diagnostics has launched the Ames Clinitek 200+, benchtop, semi-automated urine chemistry analyser for moderate to large volume urine testing....

ENZON AND CYTOCLONAL PHARMACEUTICS

6 April 1992

Enzon Inc has entered into an agreement with Cytoclonal Pharmaceutics to apply the former's drug delivery technologies to Cytoclonal products...

CHUGAI'S EPOCH

6 April 1992

A small study of Chugai's Epoch (recombinant erythropoietin) has found that while giving EPO to patients receiving autologous blood donation...

NICOTINELL TTS LAUNCHED IN FRANCE

6 April 1992

Ciba-Geigy has launched its transdermal nicotine patch, Nicotinell TTS, onto the French market. The smoking cessation product is also comarketed...

STOCK MARKET COMMENTARY: TOKYO

6 April 1992

TOKYO: stocks declined last week after a brief hiatus. The Nikkei Average fell 2.8% to 19,669.311, once again below the...

FERMENTA INTO LOSS

6 April 1992

Swedish drugmaker Fermenta reported a 1.23 billion kroner ($203.4 million) loss for 1991, compared with a loss of 599 million...

Showing 94451-94460 of 95341 articles